Vanguard Group Inc Repare Therapeutics Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 52,857 shares of RPTX stock, worth $72,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,857
Previous 54,265
2.59%
Holding current value
$72,414
Previous $71,000
26.76%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RPTX
# of Institutions
54Shares Held
32.5MCall Options Held
50KPut Options Held
900-
Bvf Inc San Francisco, CA10.3MShares$14.2 Million0.45% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$4.72 Million1.76% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.55 Million0.1% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.06 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.63 Million5.46% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $57.5M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...